CRISPincette
Commercial- Indications
- Cancer diagnosis
Company intelligence / Profile preview
GeneCker
Seoul, Seoul, South Koreagenecker.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
GeneCker has developed and commercialized an ultra-sensitive genomic analysis platform using proprietary CRISPR/Cas9 technology ("gcCas9") that enables highly accurate detection of low-frequency cancer mutations from liquid biopsies. This allows for earlier and more precise cancer diagnosis compared to conventional methods. The company claims to have pioneered the world’s first commercial precision ctDNA detection platform based on CRISPR technology, with demonstrated improvements in both accuracy and speed of diagnosis[2].
- Therapeutic areas
- Oncology
- Modalities
- CRISPR-based therapyDiagnostic technology (liquid biopsy platform)
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed as of now.
Beyond the preview
Go deeper on GeneCker.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeneCker.